作者: Stamatis Katsenos , Stavros H. Constantopoulos
DOI: 10.1155/2011/325362
关键词:
摘要: Long-term oxygen therapy (LTOT) is the cornerstone mode of treatment in patients with severe chronic obstructive pulmonary disease (COPD) associated resting hypoxaemia. When appropriately prescribed and correctly used, LTOT has clearly been shown to improve survival hypoxemic COPD patients. Adherence ranges from 45% 70% utilization for more than 15 hours per day widely accepted as efficacious. Although several studies have addressed level patients' adherence LTOT, few suggested or evaluated interventions that conduce compliance enhancement. The lack sufficient data regarding following prescription an enormous void must be duly confronted augment clinical effectiveness cost containment long term use. present review article highlights factors influencing using emphasizes novel strategies may prove significant benefit given remarkably little current research appraising this issue. Therefore, additional should promptly performed verify efficacy newly designed approaches improving outcomes receiving LTOT.